4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-006312
Chief Development Officer acquired 9,625 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Longpre Lara Chief Development Officer | 2023-01-31 | Grant or award | +9,625 | 106,159 | D | ||
| Derivatives | |||||||
| Longpre Lara Chief Development Officer | 2023-01-31 | Grant or award · Stock Option (right to buy) | +38,500 | 38,500 | D | ||
Loading xslF345X03/doc4.xml…